Cardiovascular disease risk factors in chronic kidney disease - Overall burden and rates of treatment and control

被引:188
作者
Parikh, Nisha I.
Hwang, Shih-Jen
Larson, Martin G.
Meigs, James B.
Levy, Daniel
Fox, Caroline S.
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA
[2] Massachusetts Gen Hosp, Div Gen Med, Dept Med, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Dept Endocrinol Diabet & Hypertens, Brigham & Womens Hosp, Boston, MA 02115 USA
[6] NHLBI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1001/archinte.166.17.1884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mild to moderate chronic kidney disease (CKD) is associated with increased risk for cardiovascular disease. The burden of cardiovascular disease risk factors in this setting is not well described. Methods: We compared the age- and sex-adjusted prevalence of cardiovascular disease risk factors and their treatment and control among persons with and without CKD in 3258 Framingham offspring cohort members who attended the seventh examination cycle (1998-2001). Glomerular filtration rate (GFR) was estimated using the simplified Modification of Diet in Renal Disease Study equation. We defined CKD as a GFR of less than 59 mL/min per 1.73 m(2) in women and less than 64 mL/min per 1.73 m(2) in men. Results: Those with CKD were older, more likely to be obese (33.5% vs 29.3%; P=.02), and more likely to have low levels of high-density lipoprotein cholesterol (45.2% vs 29.4%; P <.001) and high triglyceride levels (39.9% vs 29.8%; P <.001). Those with CKD had a higher prevalence of hypertension (71.2% vs 42.7%; P <.001) and hypertension treatment (86.0% vs 72.5%; P <.001), but were less likely to achieve optimal blood pressure control ( 27.0% vs 45.5%; P <. 001). Participants with CKD had a higher prevalence of elevated low-density lipoprotein cholesterol levels (60.5% vs 44.7%; P=.06) and lipid-lowering therapy (57.1% vs 42.6%; P=.09), although this was not statistically significant. A greater proportion of individuals with CKD than those without had diabetes (23.5% vs 11.9%; P=.02) and were receiving diabetes treatment (63.6% vs 46.9%; P=.05), but were less likely to achieve a hemoglobin A(1c) level of less than 7% (43.8% vs 59.4%; P=.03). Conclusions: Chronic kidney disease is associated with a significant burden of cardiovascular disease risk factors in the community. The diagnosis of CKD should alert the practitioner to look for potentially modifiable cardiovascular risk factors.
引用
收藏
页码:1884 / 1891
页数:8
相关论文
共 54 条
[1]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[2]  
[Anonymous], 2005, DIABETES CARE, V28, pS4
[3]   Premature cardiovascular disease in chronic renal failure [J].
Baigent, C ;
Burbury, K ;
Wheeler, D .
LANCET, 2000, 356 (9224) :147-152
[4]   Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[5]   Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction [J].
Berger, AK ;
Duval, S ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :201-208
[6]   Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population [J].
Bleyer, AJ ;
Shemanski, LR ;
Burke, GL ;
Hansen, KJ ;
Appel, RG .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2072-2079
[7]  
Burkhardt H, 2005, J NEPHROL, V18, P166
[8]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497